Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

How are government price controls going to help the people, our company, our stock price???

This bill, H.R. 3, would give the federal bureaucracy unprecedented power to set prices for prescription drugs. Rather than pursuing this measure, Congress should work toward common-sense reforms that have broad support and will ensure continued access to life-saving and life-enhancing medications.
.
.
For example, in Canada, where a government board determines drug prices, patients only have access to half of new drugs. In contrast, US patients have access to 89 percent of new drugs.

Similarly, European Union countries with price controls have experienced worsening drug shortages. The low prices limit production of the drug and what is available for patients. According to a 2019 report, in France, “The number of drugs reported as scarce in the country increased 20-fold between 2008 and 2018, according to the country’s drugs regulator — and is predicted to rise by a further 60 percent this year.” In Italy, some cancer patients struggle to access medications. In Poland, the shortage of neurological drugs rose to an “unprecedented scale.”

https://nypost.com/2021/07/10/drug-prices-set-by-washington-would-be-a-disaster-for-health-care/